Gemmer Asset Management’s Amedisys AMED Stock Holding History

Gemmer Asset Management’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-24	Closed	-$4K	–	158
2022 Q1	$4K	Hold	24	–	–	﹤0.01%	972
2021 Q4	$4K	Hold	24	–	–	﹤0.01%	1038
2021 Q3	$4K	Hold	24	–	–	﹤0.01%	1004
2021 Q2	$6K	Hold	24	–	–	﹤0.01%	993
2021 Q1	$6K	Hold	24	–	–	﹤0.01%	951
2020 Q4	$7K	Hold	24	–	–	﹤0.01%	812
2020 Q3	$6K	Hold	24	–	–	﹤0.01%	775
2020 Q2	$5K	Hold	24	–	–	﹤0.01%	818
2020 Q1	$4K	Buy	24 +4	+20%	+$712	﹤0.01%	806
2019 Q4	$3K	Hold	20	–	–	﹤0.01%	1108
2019 Q3	$3K	Hold	20	–	–	﹤0.01%	1117
2019 Q2	$2K	Hold	20	–	–	﹤0.01%	1217
2019 Q1	$2K	Hold	20	–	–	﹤0.01%	1249
2018 Q4	$2K	Buy	+20	New	+$2.36K	﹤0.01%	1186
2016 Q2	–	Sell	-140	Closed	-$6K	–	1238
2016 Q1	$6K	Hold	140	–	–	﹤0.01%	732
2015 Q4	$6K	Hold	140	–	–	﹤0.01%	746
2015 Q3	$5K	Hold	140	–	–	﹤0.01%	795
2015 Q2	$6K	Hold	140	–	–	﹤0.01%	753
2015 Q1	$4K	Hold	140	–	–	﹤0.01%	940
2014 Q4	$4K	Hold	140	–	–	﹤0.01%	916
2014 Q3	$2K	Hold	140	–	–	﹤0.01%	1113
2014 Q2	$2K	Hold	140	–	–	﹤0.01%	1138
2014 Q1	$2K	Buy	+140	New	+$2.15K	﹤0.01%	1122

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Gemmer Asset Management's AMED Position: Q2 2022 in Review

Gemmer Asset Management sold out of Amedisys (AMED) in Q2 2022, closing a stake of 24 shares — an estimated $4K sold.

Gemmer Asset Management first reported a position in AMED in Q1 2014 and held it in 23 quarters. The position peaked at $7K in Q4 2020. 288 funds tracked by Wall St. Rank hold AMED as of Q2 2022.

Gemmer Asset Management reported no remaining Amedisys position as of Q2 2022 after selling out during the quarter.
Gemmer Asset Management sold 24 Amedisys shares in Q2 2022, an estimated $4K.
Gemmer Asset Management first reported a position in Amedisys in Q1 2014 and held it in 23 quarters.
Gemmer Asset Management's Amedisys position peaked at $7K in Q4 2020.
288 funds tracked by Wall St. Rank held Amedisys as of Q2 2022.

Based on Gemmer Asset Management's 13F filing for Q2 2022, filed 22 Jul 2022.